Long-Acting Injectable HIV Therapy: Addressing Adherence Challenges

Long-acting injectable antiretroviral therapy using cabotegravir and rilpivirine (LAI CAB/RPV) has shown superior outcomes compared to daily oral ...


View article...

Top stories of the last 30 days